Compile Data Set for Download or QSAR
Found 74 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 797
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291270((R)-tert-butyl 3-(4-amino-3-iodo-1H-pyrazolo[3,4-d...)copy SMILEScopy InChI
Affinity DataIC50: 0.415nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291281(US9580432, Example 12)copy SMILEScopy InChI
Affinity DataIC50: 0.433nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291310(US9580432, Example 41)copy SMILEScopy InChI
Affinity DataIC50: 0.442nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291272((R)-4-amino-1-(1-(tert-butyloxycarbonyl)pyrrolidin...)copy SMILEScopy InChI
Affinity DataIC50: 0.443nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291276(US9580432, Example 7)copy SMILEScopy InChI
Affinity DataIC50: 0.457nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291271((R)-4-amino-1-(1-(tert-butyloxycarbonyl)piperidin-...)copy SMILEScopy InChI
Affinity DataIC50: 0.464nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291298(US9580432, Example 29)copy SMILEScopy InChI
Affinity DataIC50: 0.485nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291312(US9580432, Example 43)copy SMILEScopy InChI
Affinity DataIC50: 0.546nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291297(US9580432, Example 28)copy SMILEScopy InChI
Affinity DataIC50: 0.559nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291299(US9580432, Example 30)copy SMILEScopy InChI
Affinity DataIC50: 0.566nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291293(US9580432, Example 24 | US9580432, Example 48)copy SMILEScopy InChI
Affinity DataIC50: 0.591nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291301(US9580432, Example 32)copy SMILEScopy InChI
Affinity DataIC50: 0.634nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291288(US9580432, Example 19)copy SMILEScopy InChI
Affinity DataIC50: 0.690nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291285(US9580432, Example 16)copy SMILEScopy InChI
Affinity DataIC50: 0.733nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291275(US9580432, Example 6)copy SMILEScopy InChI
Affinity DataIC50: 0.738nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291311(US9580432, Example 42)copy SMILEScopy InChI
Affinity DataIC50: 0.771nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291290(US9580432, Example 21)copy SMILEScopy InChI
Affinity DataIC50: 0.777nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291306(US9580432, Example 37)copy SMILEScopy InChI
Affinity DataIC50: 0.786nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291284(US9580432, Example 15)copy SMILEScopy InChI
Affinity DataIC50: 0.786nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291287(US9580432, Example 18)copy SMILEScopy InChI
Affinity DataIC50: 0.788nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291303(US9580432, Example 34)copy SMILEScopy InChI
Affinity DataIC50: 0.790nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291304(US9580432, Example 35)copy SMILEScopy InChI
Affinity DataIC50: 0.792nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291324(US9580432, Example 55)copy SMILEScopy InChI
Affinity DataIC50: 0.799nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291289(US9580432, Example 20)copy SMILEScopy InChI
Affinity DataIC50: 0.801nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291286(US9580432, Example 17)copy SMILEScopy InChI
Affinity DataIC50: 0.811nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291282(US10280174, Compound A | US9580432, Example 13)copy SMILEScopy InChI
Affinity DataIC50: 0.813nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291293(US9580432, Example 24 | US9580432, Example 48)copy SMILEScopy InChI
Affinity DataIC50: 0.836nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291305(US9580432, Example 36)copy SMILEScopy InChI
Affinity DataIC50: 0.867nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291313(US9580432, Example 44)copy SMILEScopy InChI
Affinity DataIC50: 0.877nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291302(US9580432, Example 33)copy SMILEScopy InChI
Affinity DataIC50: 0.887nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291273(5-cyanobenzo[d]oxazol-2-amine | US9580432, Example...)copy SMILEScopy InChI
Affinity DataIC50: 0.888nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291307(US9580432, Example 38)copy SMILEScopy InChI
Affinity DataIC50: 0.888nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291308(US9580432, Example 39)copy SMILEScopy InChI
Affinity DataIC50: 1.12nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291294(US9580432, Example 25)copy SMILEScopy InChI
Affinity DataIC50: 1.17nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291321(US9580432, Example 52)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291274(US9580432, Example 5)copy SMILEScopy InChI
Affinity DataIC50: 1.25nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291314(US9580432, Example 45)copy SMILEScopy InChI
Affinity DataIC50: 1.25nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291277(US9580432, Example 8)copy SMILEScopy InChI
Affinity DataIC50: 1.27nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291325(US9580432, Example 56)copy SMILEScopy InChI
Affinity DataIC50: 1.34nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291278(US9580432, Example 9)copy SMILEScopy InChI
Affinity DataIC50: 1.37nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291319(US9580432, Example 50)copy SMILEScopy InChI
Affinity DataIC50: 1.41nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291296(US9580432, Example 27)copy SMILEScopy InChI
Affinity DataIC50: 1.43nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291323(US9580432, Example 54)copy SMILEScopy InChI
Affinity DataIC50: 1.44nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291320(US9580432, Example 51)copy SMILEScopy InChI
Affinity DataIC50: 1.48nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291326(US9580432, Example 57)copy SMILEScopy InChI
Affinity DataIC50: 1.51nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291328(US9580432, Example 59)copy SMILEScopy InChI
Affinity DataIC50: 1.51nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291318(US9580432, Example 49)copy SMILEScopy InChI
Affinity DataIC50: 1.53nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291292(US9580432, Example 23)copy SMILEScopy InChI
Affinity DataIC50: 1.58nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291300(US9580432, Example 31)copy SMILEScopy InChI
Affinity DataIC50: 1.67nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TAIHO PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM291322(US9580432, Example 53)copy SMILEScopy InChI
Affinity DataIC50: 1.68nMpH: 7.5Assay Description:With regard to the setting of the conditions for a method for measuring the inhibitory activity of a compound against BTK kinase activity in vitro, i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0WZRUS Patent
Displayed 1 to 50 (of 74 total ) | Next | Last >>
Jump to: